Form D · Biotechnology

BioSynchronicity Corp

Spokane, WA · CIK 0001848527

Offering snapshot reported Dec 2, 2025 · SEC filing

Reported sold
Yet to sell
Offering amount: $1M
Investors reported
0
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Minimum accepted$20,000 → $10,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 2, 2025AmendmentYet to sellNo comparison0SEC filing
Jul 22, 2024InitialYet to sellNo comparison0SEC filing
Jul 31, 2023Initial$10,000No comparison1SEC filing
Jun 28, 2023Initial$25,000No comparison2SEC filing
Jul 26, 2022Initial$150,000No comparison0SEC filing
Mar 2, 2021Initial$130,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-519380

Source: Form D, filed Dec 2, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Katz Director
Bharat Rao Director
Muriel Wood Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Registered Agents Inc. 100 N. Howard St, Ste R
Spokane, WA, 99201